nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.05.2012 | Letter to the Editor

Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients

verfasst von: Mohsen Beheshti, Werner Langsteger

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Picchio M, Spinapolice EG, Fallanca F, Crivellaro C, Giovacchini G, Gianolli L, et al. [(11)C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. Eur J Nucl Med Mol Imaging 2012;39:13–26. doi:10.1007/s00259-011-1920-z.

Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W, et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging 2008;35:1766–74.PubMedCrossRef

Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001;42:1800–4.PubMed

Beheshti M, Langsteger W, Fogelman I. Prostate cancer: role of SPECT and PET in imaging bone metastases. Semin Nucl Med 2009;39:396–407. doi:10.1053/j.semnuclmed.2009.05.003.PubMedCrossRef

Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35:135–42.PubMedCrossRef

Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Hammer J, et al. The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT. Mol Imaging Biol 2009;11:446–54.PubMedCrossRef

Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 2005;32:1253–8.PubMedCrossRef

Beheshti M, Vali R, Nader M, Poecher S, Stoiber F, Fitz F, et al. Potential value of F-18 fluor choline PET-CT in detection of bone metastases in patients with prostate cancer. J Nucl Med 2007;48(Suppl 2):193P.

Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73–92.PubMedCrossRef

Titel: Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients
verfasst von: Mohsen Beheshti
Werner Langsteger
Publikationsdatum: 01.05.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-011-2046-z

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

PET/CT imaging of 90Y radiation synovectomy

PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?

Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization

Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates

Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs